While new immunotherapy options are gaining attention in mesothelioma, older chemotherapy treatments such as gemcitabine may still offer benefits for some patients, oncologists say. Results from a Dutch trial of switch-maintenance gemcitabine have shown significant improvement in progression-free survival with gemcitabine when used after first-line chemotherapy in patients with unresectable malignant mesothelioma. The phase 2 ...
Older therapy is new maintenance option for patients with mesothelioma
By Michael Woodhead
3 Feb 2021